DiRaimondo Thomas

DiRaimondo Thomas is listed in filings as Chief Scientific Officer at Janux Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 2, 2026, including sale activity. Recent filings connect the profile to Janux Therapeutics, Inc. (JANX). The current snapshot covers public activity from Sep 27, 2024 to Jan 2, 2026. Reported amounts are shown as $1.5M to $4.5M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.